<add><doc>
	<field name = "DATE">18-MAR-1987 11:21:06.19</field>
	<field name = "PLACES">usa</field>
	<field name = "titulo">LYPHOMED LMED> TO MARKET ANTIBIOTIC</field>
	<field name = "DATELINE">ROSEMONT, ILL., March 18 -</field>
	<field name = "content">LyphoMed Inc said the Food and
Drug Administration gave it approval to market Vancomycin HCL,
an antibiotic used in hospitals to treat life-threatening
infections.
    It said the product is currently marketed by Eli Lilly and
Co LLY> under the trade name Vancocin. Sales in 1986 were 110
mln dlrs.
    LyphoMed said its objective is to get a 15 to 20 pct share
of the market.
 Reuter</field>
</doc></add>
